#Kaposi sarcoma

Researchers looked both at the first and second time people with HIV have been diagnosed with cancer.

Six out of nine patients experienced cancer remission with Opdivo or Keytruda.

A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)

Its decline after the advent of antiretroviral therapy did not extend to Black men in the South.

An estimated 7,760 HIV-positive U.S. residents were diagnosed with cancer in 2010.

Declining rates are expected for Kaposi sarcoma, non–Hodgkin lymphoma, cervical and lung cancer and Hodgkin lymphoma, among others.

However, older people with HIV have a lower rate of a few other cancers compared with the general population.

However, compared with the general population, HIV-positive individuals remain at higher risk for a slew of malignancies.

National Comprehensive Cancer Network releases new Guidelines for best practices for treating patients with kaposi sarcoma

Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials.

With the HIV population aging, it is increasingly at risk of such age-related cancers.

However, compared with the general population, HIV-positive individuals remain at higher risk for a slew of malignancies.

Treating HIV early, before CD4s drop significantly, lowers the risk of infection-related cancers.

A psychotherapist recalls her first client with AIDS in the years before effective treatment.

A considerable proportion of the cancers that develop in HIV-positive Americans spawn from other infections.